2651 - 2700 of 8620 Results
Title
Year
- Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice2017OPENTitle: Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system miceJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0158-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0158-zCitation Count: 57
-
OPENTitle: The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activityJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0174-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0174-zCitation Count: 76
- Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 42008OPENTitle: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Journal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 1345End Page: 1358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.049551Best OA location URL: http://doi.org/10.1124/mol.108.049551Citation Count: 185
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease2011OPENTitle: Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 1048End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.11Best OA location URL: http://www.cell.com/article/S1525001616319098/pdfCitation Count: 139
- Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV2018OPENTitle: Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBVJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 24Issue #: 3Start Page: 322End Page: 327Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0130-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6363916Citation Count: 64
- Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine Model2011OPENTitle: Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine ModelJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 544End Page: 554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.216Best OA location URL: http://www.cell.com/article/S1525001616305111/pdfCitation Count: 30
-
OPENTitle: Long-term Transgene Expression in the Central Nervous System Using DNA NanoparticlesJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 641End Page: 650Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.2Best OA location URL: http://www.cell.com/article/S152500161631557X/pdfCitation Count: 77
- Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate Brain2009OPENTitle: Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate BrainJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 3Start Page: 588End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.286Best OA location URL: http://www.cell.com/article/S1525001616323085/pdfCitation Count: 125
- Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s Disease2013OPENTitle: Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 2169End Page: 2180Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2013.169Best OA location URL: http://www.cell.com/article/S1525001616309431/pdfCitation Count: 55
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors2010OPENTitle: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 1490End Page: 1495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2010.114Best OA location URL: http://www.cell.com/article/S1525001616310991/pdfCitation Count: 80
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease2011OPENTitle: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 11Start Page: 2051End Page: 2057Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23792Citation Count: 83
-
OPENTitle: Comparison of enrollees and decliners of Parkinson disease sham surgery trialsJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 4Start Page: 506End Page: 511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24940Best OA location URL: https://hdl.handle.net/2027.42/90524Citation Count: 15
- Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study2011OPENTitle: Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker StudyJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2283End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23934Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3337217Citation Count: 23
- Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian rats2008OPENTitle: Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 1572End Page: 1579Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2008.146Best OA location URL: http://www.cell.com/article/S1525001616320548/pdfCitation Count: 116
-
OPENTitle: Obesity, diabetes, and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2253End Page: 2259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23855Citation Count: 155
-
OPENTitle: The association between Mediterranean diet adherence and Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 6Start Page: 771End Page: 774Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24918Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3349773Citation Count: 203
-
OPENTitle: Brain biochemistry in autopsied patients with essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 113End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3261329Citation Count: 55
-
OPENTitle: Brain amyloid and cognition in Lewy body diseasesJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 8Start Page: 965End Page: 973Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25048Citation Count: 168
-
OPENTitle: Sham surgery controls in Parkinson's disease clinical trials: Views of participantsJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 11Start Page: 1461End Page: 1465Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25155Best OA location URL: https://hdl.handle.net/2027.42/93771Citation Count: 19
-
OPENTitle: Genetic modification of the association of paraquat and Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 13Start Page: 1652End Page: 1658Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25216Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3572192Citation Count: 89
- Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implications2013OPENTitle: Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implicationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 9Start Page: 1301End Page: 1304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25496Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3760996Citation Count: 38
-
OPENTitle: Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 10Start Page: 1875End Page: 1880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23746Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3972755Citation Count: 40
-
OPENTitle: Caffeine and risk of Parkinson's disease in a large cohort of men and womenJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 10Start Page: 1276End Page: 1282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25076Citation Count: 183
- Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients2013OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859714Citation Count: 7
-
OPENTitle: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1966End Page: 1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25647Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859844Citation Count: 136
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia2012OPENTitle: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 296End Page: 301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25213Best OA location URL: https://hdl.handle.net/2027.42/97160Citation Count: 87
-
OPENTitle: Caffeine consumption and risk of dyskinesia in CALM‐PDJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 380End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3608707Citation Count: 54
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: http://doi.org/10.1002/mds.25644Citation Count: 10
-
OPENTitle: Disease‐related and genetic correlates of psychotic symptoms in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2190End Page: 2195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23806Best OA location URL: http://doi.org/10.1002/mds.23806Citation Count: 69
-
OPENTitle: Reliability of a new scale for essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 12Start Page: 1567End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25162Citation Count: 205
- Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography study2014OPENTitle: Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography studyJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25929Best OA location URL: https://hdl.handle.net/2027.42/108363Citation Count: 112
-
OPENTitle: In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriersJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1197End Page: 1201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25893Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4139463Citation Count: 18
-
OPENTitle: Measuring mild cognitive impairment in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 5Start Page: 626End Page: 633Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25426Best OA location URL: https://hdl.handle.net/2027.42/98243Citation Count: 134
-
OPENTitle: The effect of deep brain stimulation randomized by site on balance in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 7Start Page: 949End Page: 953Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25831Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4057940Citation Count: 50
-
OPENTitle: Evaluation of mild cognitive impairment subtypes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 756End Page: 764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25875Best OA location URL: http://doi.org/10.1002/mds.25875Citation Count: 57
- Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging2011OPENTitle: Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imagingJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23917Best OA location URL: http://doi.org/10.1002/mds.23917Citation Count: 176
-
OPENTitle: Results of the citalopram to enhance cognition in Huntington disease trialJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 3Start Page: 401End Page: 405Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25750Best OA location URL: http://doi.org/10.1002/mds.25750Citation Count: 59
-
OPENTitle: Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐MennonitesJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25818Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4013240Citation Count: 38
-
OPENTitle: Barriers to investigator-initiated deep brain stimulation and device researchJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 16Start Page: 1465End Page: 1473Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000345Best OA location URL: https://n.neurology.org/content/neurology/82/16/1465.full.pdfCitation Count: 17
-
OPENTitle: Naltrexone for impulse control disorders in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 9Start Page: 826End Page: 833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000729Best OA location URL: https://n.neurology.org/content/neurology/83/9/826.full.pdfCitation Count: 88
-
OPENTitle: Imaging prodromal Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 19Start Page: 1739End Page: 1746Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000960Best OA location URL: https://n.neurology.org/content/neurology/83/19/1739.full.pdfCitation Count: 158
-
OPENTitle: Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of AgingJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 14Start Page: 1433End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001437Best OA location URL: https://n.neurology.org/content/neurology/84/14/1433.full.pdfCitation Count: 126
-
OPENTitle: Physician response to a medication alert system in inpatients with levodopa-treated diseasesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 5Start Page: 420End Page: 424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001745Best OA location URL: https://n.neurology.org/content/neurology/85/5/420.full.pdfCitation Count: 5
-
OPENTitle: When DLB, PD, and PSP masquerade as MSAJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 5Start Page: 404End Page: 412Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000001807Best OA location URL: https://n.neurology.org/content/neurology/85/5/404.full.pdfCitation Count: 307
-
OPENTitle: Placebo effect of medication cost in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 8Start Page: 794End Page: 802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001282Best OA location URL: https://n.neurology.org/content/neurology/84/8/794.full.pdfCitation Count: 129
-
OPENTitle: Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 4Start Page: 399End Page: 406Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001189Best OA location URL: https://n.neurology.org/content/neurology/84/4/399.full.pdfCitation Count: 73
- Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD2014OPENTitle: Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PDJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 4Start Page: 415End Page: 420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001184Best OA location URL: https://n.neurology.org/content/neurology/84/4/415.full.pdfCitation Count: 170
-
OPENTitle: Parkinson disease and incidental Lewy body diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 19Start Page: 1670End Page: 1679Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000002102Best OA location URL: https://n.neurology.org/content/neurology/85/19/1670.full.pdfCitation Count: 100
-
OPENTitle: Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 1Start Page: 89End Page: 95Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001708Best OA location URL: https://n.neurology.org/content/neurology/85/1/89.full.pdfCitation Count: 158
-
OPENTitle: Teaching Neuro Images : Recurrent SSPE presenting as Anton syndrome with cortical ribboningJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000002096Best OA location URL: https://n.neurology.org/content/neurology/85/19/e141.full.pdfCitation Count: 3